Granahan Investment Management - HARVARD BIOSCIENCE INC ownership

HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 81 filers reported holding HARVARD BIOSCIENCE INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of HARVARD BIOSCIENCE INC
ValueSharesWeighting
Q3 2023$7,462,960
-5.6%
1,735,572
+20.6%
0.27%
+9.5%
Q2 2023$7,902,581
+31.6%
1,439,450
+0.7%
0.24%
+32.8%
Q1 2023$6,006,634
+48.3%
1,430,151
-2.2%
0.18%
+47.6%
Q4 2022$4,051,006
+6.0%
1,462,457
-2.1%
0.12%
-0.8%
Q3 2022$3,823,000
-30.7%
1,493,269
-2.6%
0.12%
-33.5%
Q2 2022$5,518,000
-39.0%
1,532,693
+5.2%
0.19%
-16.4%
Q1 2022$9,046,000
-22.6%
1,456,749
-12.1%
0.22%
-6.6%
Q4 2021$11,688,000
+6.0%
1,657,823
+4.9%
0.24%
+15.3%
Q3 2021$11,026,000
-14.0%
1,579,655
+2.6%
0.21%
-12.6%
Q2 2021$12,825,000
+54.6%
1,539,560
+1.3%
0.24%
+35.8%
Q1 2021$8,296,000
+26.9%
1,519,323
-0.3%
0.18%
+19.7%
Q4 2020$6,535,000
+23.6%
1,523,352
-13.3%
0.15%
-17.9%
Q3 2020$5,289,000
-1.6%
1,757,176
+1.4%
0.18%
-7.7%
Q2 2020$5,373,000
+31.7%
1,733,143
-6.1%
0.19%
-11.8%
Q1 2020$4,080,000
-29.0%
1,846,148
-2.1%
0.22%
-17.0%
Q4 2019$5,749,000
+5.5%
1,884,833
+6.4%
0.26%
-11.7%
Q3 2019$5,449,000
+194.9%
1,771,964
+91.8%
0.30%
+229.7%
Q2 2019$1,848,000
-56.5%
923,773
-6.4%
0.09%
-60.1%
Q1 2019$4,253,000
+22.5%
986,701
-9.6%
0.23%
-7.3%
Q4 2018$3,472,000
-40.7%
1,091,683
-2.0%
0.25%
-22.4%
Q3 2018$5,851,000
+1.7%
1,114,490
+3.6%
0.32%
-8.6%
Q2 2018$5,753,000
+19.7%
1,075,363
+11.8%
0.35%0.0%
Q1 2018$4,808,000
+55.7%
961,647
+2.8%
0.35%
+42.8%
Q4 2017$3,088,000
+53.2%
935,717
+74.1%
0.24%
+44.6%
Q3 2017$2,016,000
+166.0%
537,467
+80.7%
0.17%
+140.0%
Q2 2017$758,000
-71.3%
297,412
-70.7%
0.07%
-73.6%
Q1 2017$2,641,000
-43.7%
1,015,728
-33.9%
0.26%
+64.6%
Q4 2016$4,690,000
+30.5%
1,537,815
+16.4%
0.16%
+36.4%
Q3 2016$3,593,000
-2.4%
1,321,115
+2.7%
0.12%
-11.9%
Q2 2016$3,680,000
-9.2%
1,286,725
-4.1%
0.13%
-8.8%
Q1 2016$4,052,000
-17.4%
1,341,795
-5.1%
0.15%
-13.0%
Q4 2015$4,904,000
-23.8%
1,413,215
-17.0%
0.17%
-15.1%
Q3 2015$6,438,000
-35.5%
1,703,046
-2.8%
0.20%
-29.7%
Q2 2015$9,986,000
+5.5%
1,751,946
+7.7%
0.28%
+4.4%
Q1 2015$9,467,000
+1.7%
1,626,636
-1.0%
0.27%
-0.4%
Q4 2014$9,312,000
+38.4%
1,642,276
-0.1%
0.27%
+30.8%
Q3 2014$6,726,000
-13.5%
1,644,590
-3.7%
0.21%
-8.4%
Q2 2014$7,772,000
-6.6%
1,708,216
-2.7%
0.23%
+1.3%
Q1 2014$8,323,000
+2.7%
1,755,916
+1.9%
0.22%
+7.7%
Q4 2013$8,103,000
+52.6%
1,723,960
+70.8%
0.21%
+47.5%
Q3 2013$5,309,000
+15.2%
1,009,325
+3.0%
0.14%
+6.0%
Q2 2013$4,607,000980,3050.13%
Other shareholders
HARVARD BIOSCIENCE INC shareholders Q4 2015
NameSharesValueWeighting ↓
AMH Equity Ltd 2,141,353$9,207,81810.12%
B. Riley Asset Management, LLC 3,262,995$14,030,8795.58%
Meros Investment Management, LP 807,117$3,470,6031.89%
Harvey Partners, LLC 2,557,500$10,997,2501.39%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 2,923,034$12,569,0460.80%
Acuitas Investments, LLC 241,781$1,039,6580.61%
BARD ASSOCIATES INC 285,922$1,229,4650.51%
Riverwater Partners LLC 81,482$350,3730.32%
Archon Capital Management LLC 279,358$1,201,2390.32%
Granahan Investment Management 1,735,572$7,462,9600.27%
View complete list of HARVARD BIOSCIENCE INC shareholders